By Sara Stefanini ( May 1, 2007, 12:00 AM EDT) -- The White House on Tuesday expressed firm opposition to any attempt to add a law that would pave the way for generic or follow-on drugs to be approved to a bill allowing the Food and Drug Administration to collect fees, which is currently being debated in the U.S. Senate....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.